EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3
Mengxian Tu(Sun Yat-sen University), Jian Hong(Anhui Medical University)
Cited by 33
Related Papers
Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
|Journal of Cellular and Molecular Medicine|2013|103
TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration
|Frontiers in Immunology|2021|75
TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes
|Frontiers in Oncology|2022|10
Enhanced Expression of ARK5 in Hepatic Stellate Cell and Hepatocyte Synergistically Promote Liver Fibrosis
|International Journal of Molecular Sciences|2022|5